Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2004-002569-19Phase 2Completed
Phase 2 trial of alfacalcidol in asthma (2 arms), sponsored by Department of Asthma, Allergy and Respiratory Science. Primary endpoint: Change in IL-10 production by peripheral blood T cells. Started Feb 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2004-002569-19.